According to Takeda Pharmaceutical's latest financial reports the company's current earnings (TTM) are $2.28 B. In 2022 the company made an earning of $3.17 B a decrease over its 2021 earnings that were of $5.39 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | $2.28 B | -28.11% |
2022 | $3.17 B | -41.15% |
2021 | $5.39 B | 78.15% |
2020 | $3.02 B | 246.83% |
2019 | $0.87 B | -48.74% |
2018 | $1.70 B | -23.86% |
2017 | $2.23 B | 21.77% |
2016 | $1.83 B | -253.22% |
2015 | -$1.2 B | -159.7% |
2014 | $2.00 B | 12.76% |
2013 | $1.78 B | 2.7% |
2012 | $1.73 B | -57.11% |
2011 | $4.04 B | -10.11% |
2010 | $4.50 B | -4.2% |
2009 | $4.69 B |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $16.97 B | 643.27% | ๐บ๐ธ USA |
Novartis NVS | $9.43 B | 313.33% | ๐จ๐ญ Switzerland |
Pfizer PFE | $3.26 B | 43.07% | ๐บ๐ธ USA |
Amgen AMGN | $7.85 B | 244.00% | ๐บ๐ธ USA |
Sanofi SNY | $8.39 B | 267.66% | ๐ซ๐ท France |
Merck MRK | $3.03 B | 32.91% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $7.53 B | 229.99% | ๐ฌ๐ง UK |
Seagen
SGEN | -$0.8 B | -134.62% | ๐บ๐ธ USA |
Dr. Reddy's RDY | $0.85 B | -62.60% | ๐ฎ๐ณ India |